abrdn Life Sciences Investors

HQL

Save to watchlist Sign in to save

Latest available SEC filing: 4 ·

Latest disclosures

  • Mahai Chris LaVictoire: Form 4

    Insider disclosure · Filed · Report period 16 Jul 2026

  • Form 4

    SEC filing · Filed

  • Form 3

    SEC filing · Filed

  • Form 3

    SEC filing · Filed

  • Form 4

    SEC filing · Filed

  • Form 4

    SEC filing · Filed

  • Form 4

    SEC filing · Filed

All company filings

Institutional holders by security

Choose a share class to see reported 13F positions and quarterly changes. Different securities have separate holder histories.

  • HQL · 87911K100 - Common
  • HQL · 404053100 - EXCHANGE TRADED
Company details and SEC sources

CIK 0000884121 · SEC filing index. Filing dates describe disclosures, not live market data.

Listed symbols
HQL on NYSE
At a glance Names, identifiers, and filing context for this profile. 1 identity field
Business address
1900 Market Street, Suite 200, Philadelphia, PA, 19103
EDGAR profile Static EDGAR fields kept behind disclosure so the main profile stays readable. 3 profile fields available
Incorporated in
MA
Fiscal year end
30 September
Former names on EDGAR
TEKLA LIFE SCIENCES INVESTORS (to 05 Oct 2023), H&Q LIFE SCIENCES INVESTORS (to 18 Sep 2014)
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .